US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Moleculin Biotech

0.7373

-0.0926-11.16%

Volume:1.74M

Turnover:1.38M

Market Cap:14.36M

PE:-0.08

High:0.8990

Open:0.8500

Low:0.7100

Close:0.8299

52wk High:15.75

52wk Low:0.1614

Shares:19.48M

Float Shares:17.03M

Volume Ratio:3.97

T/O Rate:10.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.5973

EPS(LYR):-28.4188

ROE:-1371.64%

ROA:-84.57%

PB:1.24

PE(LYR):-0.03

Loading ...

Overview Company News Filings

Moleculin Biotech Q1 EPS $(3.54) Misses $(1.57) Estimate

Benzinga Earnings

Moleculin Biotech Q1 net loss widens as R&D costs rise

Moleculin Biotech Q1 EPS USD -3.54

THOMSON REUTERS

Moleculin reports 40% blinded remission rate in pivotal MIRACLE AML trial

Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal Miracle Trial

THOMSON REUTERS

Moleculin Biotech Inc reports results for the quarter ended March 31 - Earnings Summary

Moleculin Biotech Q1 FY26 net loss widens to $12.85 million; operating loss widens to $7.87 million

Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target

Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding

Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30

BRIEF-Moleculin Biotech Inc - To Unblind Miracle Trial Data Before June 30, 2026 - SEC Filing

Moleculin Biotech Inc - Miracle Trial on Track to Complete Part a Recruitment in Q3 2026 - SEC Filing

THOMSON REUTERS

Moleculin nears MIRACLE trial unblinding for Annamycin in relapsed AML by June 30

Moleculin announces publication on cardiac safety profiloe of annamycin

Moleculin says Cleveland Clinic review finds no significant Annamycin cardiotoxicity in R/R AML

Moleculin Biotech issued liposomal Annamycin patent in Hong Kong

Moleculin Biotech secures Hong Kong patent for liposomal Annamycin reconstitution method

Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

Moleculin says Annamycin extends survival 60% in pancreatic cancer preclinical models

Moleculin to present annamycin cardiac safety pooled analysis at ASCO 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/MBRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBRX\",,,,,undefined,":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech","latestPrice":0.7373,"timestamp":1789151246591,"preClose":0.8299,"halted":0,"volume":1741112,"delay":0,"changeRate":-0.11157970839860226,"floatShares":17031100,"shares":19477400,"eps":-9.597297,"marketStatus":"Trading","change":-0.0926,"latestTime":"09-11 14:28:15 EDT","open":0.85,"high":0.899,"low":0.71,"amount":1377487.67101464,"amplitude":0.227738,"askPrice":0.7499,"askSize":100,"bidPrice":0.6958,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-9.597297,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.8299,"preHourTrading":{"tag":"盘前","latestPrice":0.8449,"preClose":0.8299,"latestTime":"09:04 EDT","volume":14030,"amount":11821.1168,"timestamp":1789131874108,"change":0.015,"changeRate":0.018074,"amplitude":0.047235},"postHourTrading":{"tag":"盘后","latestPrice":0.8148,"preClose":0.8299,"latestTime":"19:23 EDT","volume":10543,"amount":8734.89282,"timestamp":1789082614506,"change":-0.0151,"changeRate":-0.018195,"amplitude":0.022653},"volumeRatio":3.970034},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBRX\",,,,,undefined,":{"symbol":"MBRX","floatShares":17031100,"roa":"-84.57%","roe":"-1371.64%","lyrEps":-28.418775,"volumeRatio":3.970034,"shares":19477400,"dividePrice":0,"high":0.899,"amplitude":0.227738,"preClose":0.8299,"low":0.71,"week52Low":0.1614,"pbRate":"1.24","week52High":15.75,"institutionHeld":0,"latestPrice":0.7373,"committee":0.904762,"eps":-9.597297,"divideRate":0,"volume":1741112,"delay":0,"ttmEps":-9.597297,"open":0.85,"prevYearClose":3.31,"prevWeekClose":0.7099,"prevMonthClose":0.6447,"prevQuarterClose":2.79,"fiveDayClose":0.6755,"twentyDayClose":0.5713,"sixtyDayClose":2.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"MBRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2026-05-14","symbol":"MBRX","fiscalQuarterEnding":"2026/03","expectedEps":-1.69,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-2.48},{"market":"US","date":"2026-03-19","symbol":"MBRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-12-01","symbol":"MBRX","defaultRemindTime":1764599400000,"type":"split","dateTimestamp":1764565200000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2025-11-13","symbol":"MBRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.2,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MBRX","date":"2026-09-10","current":-0.086472,"percent":0.612797,"low":-6.031202,"twenty":-1.97581,"median":-0.619627,"eighty":-0.295337,"high":-0.041817,"avg":-1.147568,"sd":1.249254,"marketCap":14900195},"quantilePoints":[{"date":"2021-09-17","current":-6.031202,"twenty":-6.657551,"median":-4.57079,"eighty":-3.027649,"marketCap":88797382},{"date":"2021-09-24","current":-5.740308,"twenty":-6.647625,"median":-4.571143,"eighty":-3.028316,"marketCap":84514550},{"date":"2021-10-01","current":-5.430021,"twenty":-6.640295,"median":-4.595196,"eighty":-3.035197,"marketCap":79946196},{"date":"2021-10-08","current":-5.255484,"twenty":-6.638349,"median":-4.600065,"eighty":-3.045512,"marketCap":77376497},{"date":"2021-10-15","current":-5.255484,"twenty":-6.638349,"median":-4.61476,"eighty":-3.049661,"marketCap":77376497},{"date":"2021-10-22","current":-5.333056,"twenty":-6.633061,"median":-4.625073,"eighty":-3.049749,"marketCap":78518585},{"date":"2021-10-29","current":-5.119734,"twenty":-6.629535,"median":-4.655883,"eighty":-3.049749,"marketCap":75377842},{"date":"2021-11-05","current":-5.003376,"twenty":-6.603268,"median":-4.664895,"eighty":-3.049749,"marketCap":73664709},{"date":"2021-11-12","current":-4.493596,"twenty":-6.573592,"median":-4.662654,"eighty":-3.050384,"marketCap":70585407},{"date":"2021-11-19","current":-4.002393,"twenty":-6.559225,"median":-4.651352,"eighty":-3.050808,"marketCap":62869593},{"date":"2021-11-26","current":-3.91143,"twenty":-6.546414,"median":-4.625073,"eighty":-3.054203,"marketCap":61440739},{"date":"2021-12-03","current":-3.583961,"twenty":-6.533455,"median":-4.615601,"eighty":-3.064281,"marketCap":56296863},{"date":"2021-12-10","current":-4.238898,"twenty":-6.528828,"median":-4.603452,"eighty":-3.071796,"marketCap":66584615},{"date":"2021-12-17","current":-3.893237,"twenty":-6.521887,"median":-4.595196,"eighty":-3.071849,"marketCap":61154968},{"date":"2021-12-23","current":-3.693117,"twenty":-6.521887,"median":-4.590744,"eighty":-3.071849,"marketCap":58011488},{"date":"2021-12-31","current":-3.383842,"twenty":-6.521887,"median":-4.57079,"eighty":-3.071849,"marketCap":53153383},{"date":"2022-01-07","current":-3.311071,"twenty":-6.521887,"median":-4.564726,"eighty":-3.071849,"marketCap":52010300},{"date":"2022-01-14","current":-3.110951,"twenty":-6.517795,"median":-4.554887,"eighty":-3.071849,"marketCap":48866820},{"date":"2022-01-21","current":-2.783483,"twenty":-6.501428,"median":-4.544849,"eighty":-3.071849,"marketCap":43722944},{"date":"2022-01-28","current":-2.56517,"twenty":-6.493648,"median":-4.53412,"eighty":-3.056373,"marketCap":40293694},{"date":"2022-02-04","current":-2.710712,"twenty":-6.493648,"median":-4.525978,"eighty":-3.049749,"marketCap":42579861},{"date":"2022-02-11","current":-2.692519,"twenty":-6.478297,"median":-4.518786,"eighty":-3.049528,"marketCap":42294090},{"date":"2022-02-18","current":-2.474207,"twenty":-6.469401,"median":-4.493679,"eighty":-3.027649,"marketCap":38864839},{"date":"2022-02-25","current":-2.56517,"twenty":-6.464804,"median":-4.493596,"eighty":-3.027649,"marketCap":40293694},{"date":"2022-03-04","current":-2.401436,"twenty":-6.463655,"median":-4.474466,"eighty":-3.005507,"marketCap":37721756},{"date":"2022-03-11","current":-2.383243,"twenty":-6.463655,"median":-4.4674,"eighty":-3.002188,"marketCap":37435985},{"date":"2022-03-18","current":-2.692519,"twenty":-6.445671,"median":-4.424589,"eighty":-2.98345,"marketCap":42294090},{"date":"2022-03-25","current":-3.182563,"twenty":-6.438135,"median":-4.406707,"eighty":-2.977299,"marketCap":50583658},{"date":"2022-04-01","current":-3.272466,"twenty":-6.437375,"median":-4.399361,"eighty":-2.982508,"marketCap":52012575},{"date":"2022-04-08","current":-3.326408,"twenty":-6.405363,"median":-4.352398,"eighty":-2.982508,"marketCap":52869925},{"date":"2022-04-14","current":-3.596117,"twenty":-6.373321,"median":-4.313035,"eighty":-2.982508,"marketCap":57156676},{"date":"2022-04-22","current":-3.272466,"twenty":-6.347193,"median":-4.303161,"eighty":-2.982508,"marketCap":52012575},{"date":"2022-04-29","current":-2.858913,"twenty":-6.326447,"median":-4.268566,"eighty":-2.962474,"marketCap":45439557},{"date":"2022-05-06","current":-2.643146,"twenty":-6.277248,"median":-4.216616,"eighty":-2.953539,"marketCap":42010156},{"date":"2022-05-13","current":-1.934764,"twenty":-6.230731,"median":-4.173408,"eighty":-2.937568,"marketCap":35437139},{"date":"2022-05-20","current":-2.043985,"twenty":-6.230731,"median":-4.135144,"eighty":-2.89691,"marketCap":37437622},{"date":"2022-05-27","current":-2.356043,"twenty":-6.230731,"median":-4.100664,"eighty":-2.893757,"marketCap":43153290},{"date":"2022-06-03","current":-2.387249,"twenty":-6.216696,"median":-4.075277,"eighty":-2.876893,"marketCap":43724857},{"date":"2022-06-10","current":-2.34044,"twenty":-6.180904,"median":-4.058788,"eighty":-2.869844,"marketCap":42867507},{"date":"2022-06-17","current":-2.324837,"twenty":-6.133327,"median":-4.028164,"eighty":-2.855029,"marketCap":42581723},{"date":"2022-06-24","current":-2.278029,"twenty":-6.07916,"median":-4.012846,"eighty":-2.850547,"marketCap":41724373},{"date":"2022-07-01","current":-2.293632,"twenty":-6.019566,"median":-4.004608,"eighty":-2.849536,"marketCap":42010156},{"date":"2022-07-08","current":-2.636896,"twenty":-5.963394,"median":-4.004608,"eighty":-2.830815,"marketCap":48297391},{"date":"2022-07-15","current":-2.580258,"twenty":-5.940997,"median":-3.994243,"eighty":-2.819408,"marketCap":47259997},{"date":"2022-07-22","current":-2.948955,"twenty":-5.928624,"median":-3.973281,"eighty":-2.818063,"marketCap":54013058},{"date":"2022-07-29","current":-2.636896,"twenty":-5.876058,"median":-3.954705,"eighty":-2.806653,"marketCap":48297391},{"date":"2022-08-05","current":-2.652499,"twenty":-5.815779,"median":-3.940978,"eighty":-2.784554,"marketCap":48583174},{"date":"2022-08-12","current":-2.222786,"twenty":-5.766607,"median":-3.93784,"eighty":-2.76529,"marketCap":46342863},{"date":"2022-08-19","current":-2.305111,"twenty":-5.752805,"median":-3.91143,"eighty":-2.755163,"marketCap":48059266},{"date":"2022-08-26","current":-2.016972,"twenty":-5.720382,"median":-3.908675,"eighty":-2.745889,"marketCap":42051857},{"date":"2022-09-02","current":-1.962089,"twenty":-5.670493,"median":-3.900336,"eighty":-2.722463,"marketCap":40907589},{"date":"2022-09-09","current":-1.97581,"twenty":-5.640183,"median":-3.893237,"eighty":-2.714667,"marketCap":41193656},{"date":"2022-09-16","current":-1.797438,"twenty":-5.596232,"median":-3.876372,"eighty":-2.703491,"marketCap":37474784},{"date":"2022-09-23","current":-1.577904,"twenty":-5.526985,"median":-3.862833,"eighty":-2.695817,"marketCap":32897711},{"date":"2022-09-30","current":-1.454415,"twenty":-5.440626,"median":-3.841713,"eighty":-2.690922,"marketCap":30323108},{"date":"2022-10-07","current":-1.481857,"twenty":-5.411208,"median":-3.82533,"eighty":-2.674744,"marketCap":30895242},{"date":"2022-10-14","current":-1.37209,"twenty":-5.371842,"median":-3.811766,"eighty":-2.668102,"marketCap":28606706},{"date":"2022-10-21","current":-1.286334,"twenty":-5.344063,"median":-3.787827,"eighty":-2.661258,"marketCap":26818786},{"date":"2022-10-28","current":-1.357958,"twenty":-5.332588,"median":-3.784081,"eighty":-2.655824,"marketCap":28312056},{"date":"2022-11-04","current":-1.272339,"twenty":-5.288972,"median":-3.765888,"eighty":-2.64511,"marketCap":26526998},{"date":"2022-11-11","current":-1.073658,"twenty":-5.255484,"median":-3.750324,"eighty":-2.637068,"marketCap":26927334},{"date":"2022-11-18","current":-1.198533,"twenty":-5.23884,"median":-3.74716,"eighty":-2.636896,"marketCap":30059218},{"date":"2022-11-25","current":-1.472484,"twenty":-5.218697,"median":-3.714856,"eighty":-2.626865,"marketCap":36929896},{"date":"2022-12-02","current":-1.539373,"twenty":-5.197645,"median":-3.714856,"eighty":-2.621231,"marketCap":38607487},{"date":"2022-12-09","current":-1.518142,"twenty":-5.180271,"median":-3.693117,"eighty":-2.606679,"marketCap":38075009},{"date":"2022-12-16","current":-1.483899,"twenty":-5.158922,"median":-3.655815,"eighty":-2.601296,"marketCap":37216175},{"date":"2022-12-23","current":-1.381167,"twenty":-5.152911,"median":-3.65025,"eighty":-2.594501,"marketCap":34639670},{"date":"2022-12-30","current":-1.209948,"twenty":-5.124997,"median":-3.617947,"eighty":-2.587166,"marketCap":30345496},{"date":"2023-01-06","current":-1.381167,"twenty":-5.124997,"median":-3.585684,"eighty":-2.576597,"marketCap":34639670},{"date":"2023-01-13","current":-1.483899,"twenty":-5.124997,"median":-3.564996,"eighty":-2.56247,"marketCap":37216175},{"date":"2023-01-20","current":-1.461069,"twenty":-5.124997,"median":-3.553341,"eighty":-2.547444,"marketCap":36643618},{"date":"2023-01-27","current":-1.449655,"twenty":-5.121576,"median":-3.536555,"eighty":-2.539774,"marketCap":36357340},{"date":"2023-02-03","current":-1.403996,"twenty":-5.119734,"median":-3.521038,"eighty":-2.528785,"marketCap":35212227},{"date":"2023-02-10","current":-1.337563,"twenty":-5.119734,"median":-3.488735,"eighty":-2.510592,"marketCap":33546087},{"date":"2023-02-17","current":-1.472484,"twenty":-5.114394,"median":-3.483457,"eighty":-2.499636,"marketCap":36929896},{"date":"2023-02-24","current":-1.43824,"twenty":-5.090269,"median":-3.464544,"eighty":-2.493412,"marketCap":36071062},{"date":"2023-03-03","current":-1.381167,"twenty":-5.063718,"median":-3.450298,"eighty":-2.474314,"marketCap":34639670},{"date":"2023-03-10","current":-1.187119,"twenty":-5.04989,"median":-3.434291,"eighty":-2.461859,"marketCap":29772940},{"date":"2023-03-17","current":-1.118631,"twenty":-5.018906,"median":-3.424129,"eighty":-2.456738,"marketCap":28055270},{"date":"2023-03-24","current":-0.996179,"twenty":-5.001753,"median":-3.403043,"eighty":-2.435919,"marketCap":28914105},{"date":"2023-03-31","current":-0.946863,"twenty":-4.988177,"median":-3.395078,"eighty":-2.423552,"marketCap":27482713},{"date":"2023-04-06","current":-0.918154,"twenty":-4.988177,"median":-3.382543,"eighty":-2.408128,"marketCap":26649416},{"date":"2023-04-14","current":-0.946228,"twenty":-4.984446,"median":-3.365649,"eighty":-2.400207,"marketCap":27464280},{"date":"2023-04-20","current":-0.813785,"twenty":-4.984446,"median":-3.362043,"eighty":-2.387249,"marketCap":23620108},{"date":"2023-04-28","current":-0.699041,"twenty":-4.985249,"median":-3.342966,"eighty":-2.356895,"marketCap":20289672},{"date":"2023-05-05","current":-0.79344,"twenty":-4.985249,"median":-3.341543,"eighty":-2.34044,"marketCap":23029605},{"date":"2023-05-12","current":-0.7383,"twenty":-4.986857,"median":-3.328604,"eighty":-2.337487,"marketCap":22202901},{"date":"2023-05-19","current":-0.62569,"twenty":-4.98962,"median":-3.317536,"eighty":-2.324837,"marketCap":18816368},{"date":"2023-05-26","current":-0.615851,"twenty":-4.98962,"median":-3.311071,"eighty":-2.310472,"marketCap":18520485},{"date":"2023-06-02","current":-0.564538,"twenty":-4.98962,"median":-3.294916,"eighty":-2.306159,"marketCap":16977359},{"date":"2023-06-09","current":-0.610621,"twenty":-4.98962,"median":-3.278548,"eighty":-2.29487,"marketCap":18363205},{"date":"2023-06-16","current":-0.582202,"twenty":-4.992383,"median":-3.270745,"eighty":-2.291297,"marketCap":17508550},{"date":"2023-06-23","current":-0.591872,"twenty":-4.995145,"median":-3.259541,"eighty":-2.269684,"marketCap":17799370},{"date":"2023-06-30","current":-0.548552,"twenty":-4.997908,"median":-3.245815,"eighty":-2.262426,"marketCap":16496616},{"date":"2023-07-07","current":-0.564242,"twenty":-4.997908,"median":-3.2383,"eighty":-2.247347,"marketCap":16968456},{"date":"2023-07-14","current":-0.709201,"twenty":-4.997908,"median":-3.227787,"eighty":-2.217051,"marketCap":21327789},{"date":"2023-07-20","current":-0.654434,"twenty":-4.997908,"median":-3.216919,"eighty":-2.20387,"marketCap":19680798},{"date":"2023-07-28","current":-0.641409,"twenty":-5.000671,"median":-3.194941,"eighty":-2.168808,"marketCap":19289081},{"date":"2023-08-04","current":-0.611805,"twenty":-5.001212,"median":-3.177182,"eighty":-2.144839,"marketCap":18398816},{"date":"2023-08-11","current":-0.621673,"twenty":-5.001212,"median":-3.160125,"eighty":-2.07519,"marketCap":18695571},{"date":"2023-08-18","current":-0.586595,"twenty":-5.001212,"median":-3.142523,"eighty":-2.030693,"marketCap":17170815},{"date":"2023-08-25","current":-0.570403,"twenty":-5.001212,"median":-3.122596,"eighty":-2.016133,"marketCap":16696829},{"date":"2023-09-01","current":-0.570301,"twenty":-5.001212,"median":-3.104845,"eighty":-1.965194,"marketCap":16693848},{"date":"2023-09-08","current":-0.397683,"twenty":-5.001212,"median":-3.07346,"eighty":-1.948368,"marketCap":11640977},{"date":"2023-09-15","current":-0.399211,"twenty":-5.001212,"median":-3.065528,"eighty":-1.901704,"marketCap":11685693},{"date":"2023-09-22","current":-0.427726,"twenty":-5.001753,"median":-3.050808,"eighty":-1.79195,"marketCap":12520386},{"date":"2023-09-29","current":-0.430781,"twenty":-5.001753,"median":-3.049749,"eighty":-1.685173,"marketCap":12609817},{"date":"2023-10-06","current":-0.499013,"twenty":-5.001753,"median":-3.027649,"eighty":-1.609459,"marketCap":14607117},{"date":"2023-10-13","current":-0.412959,"twenty":-5.001753,"median":-3.027649,"eighty":-1.577904,"marketCap":12088134},{"date":"2023-10-20","current":-0.626313,"twenty":-5.001753,"median":-3.027649,"eighty":-1.540332,"marketCap":18333422},{"date":"2023-10-27","current":-0.496976,"twenty":-5.003376,"median":-3.028205,"eighty":-1.52385,"marketCap":14547496},{"date":"2023-11-03","current":-0.519585,"twenty":-5.003376,"median":-3.028205,"eighty":-1.506728,"marketCap":15209288},{"date":"2023-11-10","current":-0.547896,"twenty":-5.003376,"median":-3.028205,"eighty":-1.483899,"marketCap":16038018},{"date":"2023-11-17","current":-0.693345,"twenty":-5.003376,"median":-3.027649,"eighty":-1.472484,"marketCap":18214180},{"date":"2023-11-24","current":-0.636607,"twenty":-5.003376,"median":-3.027649,"eighty":-1.472484,"marketCap":16723658},{"date":"2023-12-01","current":-0.679388,"twenty":-5.003376,"median":-3.010907,"eighty":-1.454415,"marketCap":17847512},{"date":"2023-12-07","current":-0.6475,"twenty":-5.003376,"median":-3.010907,"eighty":-1.449655,"marketCap":17009838},{"date":"2023-12-15","current":-0.681998,"twenty":-5.005598,"median":-3.005336,"eighty":-1.43824,"marketCap":17916076},{"date":"2023-12-22","current":-0.76007,"twenty":-5.005598,"median":-3.005336,"eighty":-1.426825,"marketCap":19967034},{"date":"2023-12-29","current":-0.851078,"twenty":-5.00782,"median":-3.005443,"eighty":-1.418232,"marketCap":22357832},{"date":"2024-01-05","current":-1.157425,"twenty":-5.010041,"median":-3.00555,"eighty":-1.415411,"marketCap":30405553},{"date":"2024-01-12","current":-0.903555,"twenty":-5.010041,"median":-3.002764,"eighty":-1.401318,"marketCap":23736379},{"date":"2024-01-19","current":-0.701832,"twenty":-5.012263,"median":-2.975134,"eighty":-1.387165,"marketCap":18437125},{"date":"2024-01-26","current":-0.620049,"twenty":-5.010041,"median":-2.962755,"eighty":-1.381167,"marketCap":16288689},{"date":"2024-02-02","current":-0.65757,"twenty":-5.010041,"median":-2.948955,"eighty":-1.37209,"marketCap":17274363},{"date":"2024-02-09","current":-0.627044,"twenty":-5.010041,"median":-2.933352,"eighty":-1.369752,"marketCap":16472459},{"date":"2024-02-16","current":-0.635948,"twenty":-5.010041,"median":-2.903222,"eighty":-1.350843,"marketCap":16706348},{"date":"2024-02-23","current":-0.655026,"twenty":-5.010041,"median":-2.889463,"eighty":-1.324094,"marketCap":17207538},{"date":"2024-03-01","current":-0.800022,"twenty":-5.00782,"median":-2.876227,"eighty":-1.288444,"marketCap":21016585},{"date":"2024-03-08","current":-0.85217,"twenty":-5.00782,"median":-2.858329,"eighty":-1.269059,"marketCap":22386506},{"date":"2024-03-15","current":-0.681227,"twenty":-5.00782,"median":-2.850497,"eighty":-1.216797,"marketCap":17895839},{"date":"2024-03-22","current":-0.562177,"twenty":-5.00782,"median":-2.826724,"eighty":-1.187119,"marketCap":14768402},{"date":"2024-03-28","current":-0.41454,"twenty":-5.00782,"median":-2.819292,"eighty":-1.12548,"marketCap":12340438},{"date":"2024-04-05","current":-0.396581,"twenty":-5.010041,"median":-2.819868,"eighty":-1.084319,"marketCap":11805834},{"date":"2024-04-12","current":-0.356923,"twenty":-5.010041,"median":-2.817081,"eighty":-1.056695,"marketCap":10625251},{"date":"2024-04-19","current":-0.338479,"twenty":-5.010041,"median":-2.808468,"eighty":-0.951218,"marketCap":10076168},{"date":"2024-04-26","current":-0.322368,"twenty":-4.984446,"median":-2.774878,"eighty":-0.942537,"marketCap":9596584},{"date":"2024-05-03","current":-0.385357,"twenty":-4.974094,"median":-2.761076,"eighty":-0.928972,"marketCap":11471707},{"date":"2024-05-10","current":-0.357672,"twenty":-4.974094,"median":-2.747097,"eighty":-0.915662,"marketCap":10647526},{"date":"2024-05-17","current":-0.417701,"twenty":-4.974094,"median":-2.722422,"eighty":-0.898085,"marketCap":11204405},{"date":"2024-05-24","current":-0.427666,"twenty":-4.974094,"median":-2.703367,"eighty":-0.855223,"marketCap":11471707},{"date":"2024-05-31","current":-0.385314,"twenty":-4.974094,"median":-2.697971,"eighty":-0.828803,"marketCap":10335674},{"date":"2024-06-07","current":-0.384337,"twenty":-4.974094,"median":-2.690867,"eighty":-0.797102,"marketCap":10309450},{"date":"2024-06-14","current":-0.374858,"twenty":-4.974094,"median":-2.675203,"eighty":-0.790674,"marketCap":10055181},{"date":"2024-06-21","current":-0.325738,"twenty":-4.974094,"median":-2.668102,"eighty":-0.778182,"marketCap":8737606},{"date":"2024-06-28","current":-0.303333,"twenty":-4.974094,"median":-2.658563,"eighty":-0.774095,"marketCap":8136606},{"date":"2024-07-05","current":-0.312812,"twenty":-4.974094,"median":-2.656134,"eighty":-0.7557,"marketCap":8390875},{"date":"2024-07-12","current":-0.340388,"twenty":-4.974094,"median":-2.64511,"eighty":-0.713305,"marketCap":9130567},{"date":"2024-07-15","current":-0.374858,"twenty":-4.974094,"median":-2.64511,"eighty":-0.711355,"marketCap":10055181},{"date":"2024-08-02","current":-0.195615,"twenty":-4.986857,"median":-2.636896,"eighty":-0.701832,"marketCap":5247186},{"date":"2024-08-09","current":-0.189152,"twenty":-4.986857,"median":-2.625739,"eighty":-0.692211,"marketCap":5073821},{"date":"2024-08-16","current":-0.204821,"twenty":-4.986857,"median":-2.619908,"eighty":-0.672465,"marketCap":5154725},{"date":"2024-08-23","current":-0.510683,"twenty":-4.974094,"median":-2.60347,"eighty":-0.661386,"marketCap":12852365},{"date":"2024-08-30","current":-0.536006,"twenty":-4.974094,"median":-2.594501,"eighty":-0.65757,"marketCap":13489673},{"date":"2024-09-06","current":-0.525455,"twenty":-4.959273,"median":-2.58903,"eighty":-0.654434,"marketCap":13224128},{"date":"2024-09-13","current":-0.512793,"twenty":-4.925805,"median":-2.574402,"eighty":-0.651592,"marketCap":12905474},{"date":"2024-09-20","current":-0.278044,"twenty":-4.917787,"median":-2.562149,"eighty":-0.646935,"marketCap":6997536},{"date":"2024-09-27","current":-0.275784,"twenty":-4.862574,"median":-2.543279,"eighty":-0.644469,"marketCap":6940645},{"date":"2024-10-04","current":-0.278044,"twenty":-4.839659,"median":-2.530279,"eighty":-0.638873,"marketCap":6997536},{"date":"2024-10-11","current":-0.274653,"twenty":-4.839659,"median":-2.512967,"eighty":-0.635948,"marketCap":6912200},{"date":"2024-10-18","current":-0.266741,"twenty":-4.839659,"median":-2.497974,"eighty":-0.628952,"marketCap":6713083},{"date":"2024-10-25","current":-0.287086,"twenty":-4.837049,"median":-2.474207,"eighty":-0.62569,"marketCap":7225098},{"date":"2024-10-31","current":-0.287086,"twenty":-4.752061,"median":-2.460772,"eighty":-0.624124,"marketCap":7225098},{"date":"2024-11-08","current":-0.264481,"twenty":-4.713381,"median":-2.437821,"eighty":-0.621124,"marketCap":6656193},{"date":"2024-11-15","current":-0.291529,"twenty":-4.667079,"median":-2.424759,"eighty":-0.616561,"marketCap":8789588},{"date":"2024-11-22","current":-0.28177,"twenty":-4.667079,"median":-2.401436,"eighty":-0.611805,"marketCap":8495362},{"date":"2024-11-29","current":-0.275796,"twenty":-4.667079,"median":-2.387249,"eighty":-0.604465,"marketCap":8315249},{"date":"2024-12-06","current":-0.248913,"twenty":-4.667079,"median":-2.356043,"eighty":-0.59825,"marketCap":7504737},{"date":"2024-12-13","current":-0.244931,"twenty":-4.667079,"median":-2.338254,"eighty":-0.593495,"marketCap":7384661},{"date":"2024-12-20","current":-0.180213,"twenty":-4.667079,"median":-2.324837,"eighty":-0.589406,"marketCap":5433429},{"date":"2024-12-27","current":-0.176231,"twenty":-4.667079,"median":-2.310472,"eighty":-0.582084,"marketCap":5313354},{"date":"2025-01-03","current":-0.176231,"twenty":-4.667079,"median":-2.306223,"eighty":-0.575062,"marketCap":5313354},{"date":"2025-01-10","current":-0.177226,"twenty":-4.669263,"median":-2.294406,"eighty":-0.570362,"marketCap":5343373},{"date":"2025-01-17","current":-0.173244,"twenty":-4.669263,"median":-2.283926,"eighty":-0.566314,"marketCap":5223297},{"date":"2025-01-24","current":-0.175235,"twenty":-4.669263,"median":-2.265174,"eighty":-0.56442,"marketCap":5283335},{"date":"2025-01-31","current":-0.153331,"twenty":-4.669263,"median":-2.248133,"eighty":-0.562387,"marketCap":4622918},{"date":"2025-02-07","current":-0.083675,"twenty":-4.669263,"median":-2.219202,"eighty":-0.56007,"marketCap":2522792},{"date":"2025-02-14","current":-0.126448,"twenty":-4.669263,"median":-2.168808,"eighty":-0.542573,"marketCap":3812406},{"date":"2025-02-21","current":-0.139391,"twenty":-4.669263,"median":-2.136557,"eighty":-0.53664,"marketCap":4202653},{"date":"2025-02-28","current":-0.126448,"twenty":-4.669263,"median":-2.07519,"eighty":-0.529915,"marketCap":3812406},{"date":"2025-03-07","current":-0.109522,"twenty":-4.671446,"median":-2.030693,"eighty":-0.519911,"marketCap":3302084},{"date":"2025-03-14","current":-0.115496,"twenty":-4.671446,"median":-2.016972,"eighty":-0.508863,"marketCap":3482198},{"date":"2025-03-21","current":-0.108526,"twenty":-4.671446,"median":-2.016972,"eighty":-0.50182,"marketCap":3272065},{"date":"2025-03-28","current":-0.675482,"twenty":-4.671446,"median":-1.96597,"eighty":-0.498418,"marketCap":14700518},{"date":"2025-04-04","current":-0.558849,"twenty":-4.671446,"median":-1.948368,"eighty":-0.498418,"marketCap":12162229},{"date":"2025-04-11","current":-0.470329,"twenty":-4.638525,"median":-1.875116,"eighty":-0.493187,"marketCap":10235761},{"date":"2025-04-17","current":-0.591208,"twenty":-4.595196,"median":-1.701084,"eighty":-0.493187,"marketCap":12866453},{"date":"2025-04-25","current":-0.714081,"twenty":-4.566151,"median":-1.609459,"eighty":-0.49288,"marketCap":15540548},{"date":"2025-05-02","current":-0.649749,"twenty":-4.553113,"median":-1.577904,"eighty":-0.49288,"marketCap":14140498},{"date":"2025-05-09","current":-0.649749,"twenty":-4.553113,"median":-1.539373,"eighty":-0.49288,"marketCap":14140498},{"date":"2025-05-16","current":-0.549617,"twenty":-4.475418,"median":-1.506728,"eighty":-0.49288,"marketCap":12767050},{"date":"2025-05-23","current":-0.566372,"twenty":-4.368028,"median":-1.483899,"eighty":-0.49288,"marketCap":13156264},{"date":"2025-05-30","current":-0.547146,"twenty":-4.296194,"median":-1.483784,"eighty":-0.49288,"marketCap":12709648},{"date":"2025-06-06","current":-0.419707,"twenty":-4.228663,"median":-1.472484,"eighty":-0.489644,"marketCap":9749383},{"date":"2025-06-13","current":-0.406571,"twenty":-4.002393,"median":-1.461069,"eighty":-0.464266,"marketCap":9444229},{"date":"2025-06-20","current":-0.354571,"twenty":-3.940538,"median":-1.449655,"eighty":-0.442788,"marketCap":8236329},{"date":"2025-06-27","current":-0.195835,"twenty":-3.816828,"median":-1.43824,"eighty":-0.430985,"marketCap":4549053},{"date":"2025-07-03","current":-0.352742,"twenty":-3.765888,"median":-1.426825,"eighty":-0.427024,"marketCap":8193836},{"date":"2025-07-11","current":-0.554012,"twenty":-3.725864,"median":-1.415411,"eighty":-0.422336,"marketCap":12869143},{"date":"2025-07-18","current":-1.086632,"twenty":-3.615274,"median":-1.409703,"eighty":-0.422336,"marketCap":25241381},{"date":"2025-07-25","current":-0.828369,"twenty":-3.530431,"median":-1.392582,"eighty":-0.422336,"marketCap":19242173},{"date":"2025-08-01","current":-0.816665,"twenty":-3.455744,"median":-1.381167,"eighty":-0.422336,"marketCap":18970306},{"date":"2025-08-08","current":-0.880906,"twenty":-3.401293,"median":-1.37209,"eighty":-0.422336,"marketCap":20462556},{"date":"2025-08-15","current":-0.73896,"twenty":-3.383274,"median":-1.369752,"eighty":-0.422336,"marketCap":19619379},{"date":"2025-08-22","current":-0.680669,"twenty":-3.383274,"median":-1.35734,"eighty":-0.422336,"marketCap":18071756},{"date":"2025-08-29","current":-0.448418,"twenty":-3.383274,"median":-1.324094,"eighty":-0.422336,"marketCap":11905492},{"date":"2025-09-05","current":-0.432334,"twenty":-3.383842,"median":-1.28985,"eighty":-0.421853,"marketCap":11478457},{"date":"2025-09-12","current":-0.520301,"twenty":-3.383274,"median":-1.271378,"eighty":-0.422336,"marketCap":13813999},{"date":"2025-09-19","current":-0.570117,"twenty":-3.383274,"median":-1.224623,"eighty":-0.422336,"marketCap":15136616},{"date":"2025-09-26","current":-0.819756,"twenty":-3.383274,"median":-1.190488,"eighty":-0.422336,"marketCap":21764523},{"date":"2025-10-03","current":-0.932177,"twenty":-3.383274,"median":-1.124338,"eighty":-0.422336,"marketCap":24749288},{"date":"2025-10-10","current":-0.962193,"twenty":-3.383274,"median":-1.08551,"eighty":-0.422336,"marketCap":25546215},{"date":"2025-10-17","current":-0.899364,"twenty":-3.383274,"median":-1.070018,"eighty":-0.422336,"marketCap":23878113},{"date":"2025-10-24","current":-0.914279,"twenty":-3.383274,"median":-1.021953,"eighty":-0.422336,"marketCap":24274101},{"date":"2025-10-31","current":-0.842315,"twenty":-3.383274,"median":-0.97515,"eighty":-0.422336,"marketCap":22363456},{"date":"2025-11-07","current":-0.851077,"twenty":-3.383274,"median":-0.95082,"eighty":-0.422336,"marketCap":22596099},{"date":"2025-11-14","current":-0.84623,"twenty":-3.383274,"median":-0.946546,"eighty":-0.422336,"marketCap":22467403},{"date":"2025-11-21","current":-0.417396,"twenty":-3.383274,"median":-0.935191,"eighty":-0.420044,"marketCap":21458765},{"date":"2025-11-28","current":-0.270045,"twenty":-3.383274,"median":-0.928079,"eighty":-0.418029,"marketCap":13883286},{"date":"2025-12-05","current":-0.305397,"twenty":-3.380203,"median":-0.924038,"eighty":-0.414937,"marketCap":15700790},{"date":"2025-12-12","current":-0.198053,"twenty":-3.380203,"median":-0.91642,"eighty":-0.409901,"marketCap":10182095},{"date":"2025-12-19","current":-0.229509,"twenty":-3.380203,"median":-0.912974,"eighty":-0.40792,"marketCap":11799264},{"date":"2025-12-26","current":-0.233703,"twenty":-3.380203,"median":-0.905143,"eighty":-0.406728,"marketCap":12014917},{"date":"2026-01-02","current":-0.198348,"twenty":-3.380203,"median":-0.900389,"eighty":-0.403557,"marketCap":10197275},{"date":"2026-01-09","current":-0.246166,"twenty":-3.380203,"median":-0.893492,"eighty":-0.397276,"marketCap":12655631},{"date":"2026-01-16","current":-0.255749,"twenty":-3.358773,"median":-0.88622,"eighty":-0.39284,"marketCap":13148307},{"date":"2026-01-23","current":-0.285696,"twenty":-3.329922,"median":-0.873415,"eighty":-0.38937,"marketCap":14687922},{"date":"2026-01-30","current":-0.256348,"twenty":-3.272466,"median":-0.859078,"eighty":-0.385323,"marketCap":13179100},{"date":"2026-02-06","current":-0.234187,"twenty":-3.237941,"median":-0.851624,"eighty":-0.378965,"marketCap":12039785},{"date":"2026-02-13","current":-0.252515,"twenty":-3.216194,"median":-0.835718,"eighty":-0.37563,"marketCap":12982029},{"date":"2026-02-20","current":-0.160517,"twenty":-3.161891,"median":-0.815225,"eighty":-0.372789,"marketCap":8252333},{"date":"2026-02-27","current":-0.144345,"twenty":-3.085468,"median":-0.80193,"eighty":-0.363438,"marketCap":7420941},{"date":"2026-03-06","current":-0.214938,"twenty":-2.966348,"median":-0.79344,"eighty":-0.354778,"marketCap":11050166},{"date":"2026-03-13","current":-0.196706,"twenty":-2.930473,"median":-0.778317,"eighty":-0.348393,"marketCap":10112875},{"date":"2026-03-20","current":-0.302807,"twenty":-2.851104,"median":-0.769702,"eighty":-0.340905,"marketCap":10162206},{"date":"2026-03-27","current":-0.386392,"twenty":-2.76529,"median":-0.751228,"eighty":-0.338688,"marketCap":12967330},{"date":"2026-04-02","current":-0.354591,"twenty":-2.747097,"median":-0.737819,"eighty":-0.338688,"marketCap":11900060},{"date":"2026-04-10","current":-0.405474,"twenty":-2.714071,"median":-0.713216,"eighty":-0.338688,"marketCap":13607692},{"date":"2026-04-17","current":-0.381622,"twenty":-2.689837,"median":-0.700688,"eighty":-0.338688,"marketCap":12807240},{"date":"2026-04-24","current":-0.403883,"twenty":-2.656134,"median":-0.693053,"eighty":-0.338688,"marketCap":13554329},{"date":"2026-05-01","current":-0.407064,"twenty":-2.641896,"median":-0.687458,"eighty":-0.338688,"marketCap":13661056},{"date":"2026-05-08","current":-0.395933,"twenty":-2.636896,"median":-0.680948,"eighty":-0.338688,"marketCap":13287511},{"date":"2026-05-15","current":-0.34982,"twenty":-2.616936,"median":-0.675482,"eighty":-0.338688,"marketCap":11739970},{"date":"2026-05-22","current":-0.314903,"twenty":-2.56517,"median":-0.669282,"eighty":-0.325544,"marketCap":12753876},{"date":"2026-05-29","current":-0.361018,"twenty":-2.543279,"median":-0.662616,"eighty":-0.322368,"marketCap":14621599},{"date":"2026-06-05","current":-0.330714,"twenty":-2.510592,"median":-0.658817,"eighty":-0.322456,"marketCap":13394238},{"date":"2026-06-12","current":-0.355748,"twenty":-2.473318,"median":-0.656622,"eighty":-0.321146,"marketCap":14408145},{"date":"2026-06-18","current":-0.368924,"twenty":-2.435977,"median":-0.65473,"eighty":-0.321146,"marketCap":14941780},{"date":"2026-06-26","current":-0.393958,"twenty":-2.387249,"median":-0.652263,"eighty":-0.320994,"marketCap":15955686},{"date":"2026-07-02","current":-0.35443,"twenty":-2.373437,"median":-0.649749,"eighty":-0.320994,"marketCap":14354781},{"date":"2026-07-10","current":-0.321491,"twenty":-2.34044,"median":-0.647474,"eighty":-0.317538,"marketCap":13020694},{"date":"2026-07-17","current":-0.285916,"twenty":-2.310472,"median":-0.645105,"eighty":-0.314903,"marketCap":11579879},{"date":"2026-07-24","current":-0.274058,"twenty":-2.293632,"median":-0.641035,"eighty":-0.309632,"marketCap":11099608},{"date":"2026-07-31","current":-0.134394,"twenty":-2.265547,"median":-0.637057,"eighty":-0.30519,"marketCap":5443077},{"date":"2026-08-07","current":-0.050727,"twenty":-2.217051,"median":-0.635194,"eighty":-0.302807,"marketCap":2054494},{"date":"2026-08-14","current":-0.075274,"twenty":-2.157106,"median":-0.627998,"eighty":-0.299882,"marketCap":3048656},{"date":"2026-08-21","current":-0.37931,"twenty":-2.07519,"median":-0.625788,"eighty":-0.295337,"marketCap":11503340},{"date":"2026-08-28","current":-0.442314,"twenty":-2.030693,"median":-0.623676,"eighty":-0.295337,"marketCap":13414071},{"date":"2026-09-04","current":-0.433837,"twenty":-2.013618,"median":-0.621476,"eighty":-0.295337,"marketCap":13156970},{"date":"2026-09-10","current":-0.491318,"twenty":-1.97581,"median":-0.619627,"eighty":-0.295337,"marketCap":14900195}],"updateTime":1789129296318},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635708771","title":"Moleculin Biotech Q1 EPS $(3.54) Misses $(1.57) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635708771","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635708771?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:20","pubTimestamp":1778851201,"startTime":"0","endTime":"0","summary":"Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(3.54) per share which missed the analyst consensus estimate of $(1.57) by 125.48 percent. This is a 77.59 percent increase over losses of $(15.80) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52595795/moleculin-biotech-q1-eps-3-54-misses-1-57-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635082909","title":"Moleculin Biotech Q1 net loss widens as R&D costs rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2635082909","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635082909?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:44","pubTimestamp":1778849083,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Q1 net loss widens as R&D costs riseOverviewUS clinical-stage pharma reported no Q1 revenue and a wider net lossCompany achieved first 45-subject enrollment milestone in pivotal MIRA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL1N41S0KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635008282","title":"Moleculin Biotech Q1 EPS USD -3.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2635008282","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635008282?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:36","pubTimestamp":1778848586,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nPLX7DE773:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635084060","title":"Moleculin reports 40% blinded remission rate in pivotal MIRACLE AML trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635084060","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635084060?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:32","pubTimestamp":1778848347,"startTime":"0","endTime":"0","summary":"Moleculin Biotech flagged continued encouraging blinded remission trends in pivotal MIRACLE trial of Annamycin plus cytarabine in relapsed or refractory acute myeloid leukemia, supporting its push toward a potential late-stage inflection point.Early blinded results have already been presented, showing patients are responding at a level management views as meaningful in a hard-to-treat population.First interim unblinding is expected in June 2026 following enrollment of 45 subjects, setting up a near-term readout that could reshape development strategy and investor expectations.Trial enrollment is advancing toward 90 subjects in Q3 2026, with another unblinding planned, followed by start of Part B in 2H 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLCQVsb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635745084","title":"Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal Miracle Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635745084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635745084?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:30","pubTimestamp":1778848201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA3QP7HL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635172115","title":"Moleculin Biotech Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635172115","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635172115?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:42","pubTimestamp":1778794952,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc reports results for the quarter ended March 31 - Earnings SummaryMoleculin Biotech Inc MBRX.OQ reported quarterly adjusted earnings of $13.04 per share for the quarter ended Marc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R2MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635728711","title":"Moleculin Biotech Q1 FY26 net loss widens to $12.85 million; operating loss widens to $7.87 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728711?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:02","pubTimestamp":1778788950,"startTime":"0","endTime":"0","summary":"Moleculin Biotech posted a net loss of $12.85 million for the quarter ended March 31, 2026, widening from $5.9 million a year earlier.Operating loss widened to $7.87 million as research and development expense rose to $5.38 million, while general and administrative costs were $2.49 million.Cash used in operating activities increased to $6.11 million, while net cash provided by financing activities slipped to $7.61 million.Phase 2B/3 MIRACLE trial first unblinding remains on track to occur prior to June 30, 2026; preliminary blinded data for first 45 subjects showed CRc exceeding 40% with CR about 30%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL2GFXS4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635728565","title":"Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728565","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728565?lang=en_us&edition=fundamental","pubTime":"2026-05-15 03:25","pubTimestamp":1778786716,"startTime":"0","endTime":"0","summary":"Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Moleculin Biotech, retaining the price target of $10.00. Jason McCarthy has given ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-moleculin-biotech-as-miracle-trial-progress-supports-unchanged-10-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-moleculin-biotech-as-miracle-trial-progress-supports-unchanged-10-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","XBI","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635731244","title":"Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding","url":"https://stock-news.laohu8.com/highlight/detail?id=2635731244","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635731244?lang=en_us&edition=fundamental","pubTime":"2026-05-14 00:41","pubTimestamp":1778690460,"startTime":"0","endTime":"0","summary":"Moleculin Biotech nears first MIRACLE trial data unblinding as Annamycin shows higher remission rates in relapsed AML patients.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/05/13/Acute-Myeloid-Leukemia-Is-A-Subtype-Of-B_0.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/05/13/Acute-Myeloid-Leukemia-Is-A-Subtype-Of-B_0.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/05/52534429/nano-cap-moleculin-biotech-approaches-key-leukemia-trial-data-unblinding","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/05/52534429/nano-cap-moleculin-biotech-approaches-key-leukemia-trial-data-unblinding","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4585","XBI","BK4139","MBRX","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635339687","title":"Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2635339687","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635339687?lang=en_us&edition=fundamental","pubTime":"2026-05-13 22:09","pubTimestamp":1778681393,"startTime":"0","endTime":"0","summary":"Moleculin Biotech (MBRX) announced it is approaching the first unblinding of data from its pivotal Phase 2B/3 “MIRACLE” trial evaluating Annamycin ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-expects-first-unblinding-of-miracle-trial-data-by-june-30-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-expects-first-unblinding-of-miracle-trial-data-by-june-30-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","MBRX","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635378441","title":"BRIEF-Moleculin Biotech Inc - To Unblind Miracle Trial Data Before June 30, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635378441","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635378441?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:12","pubTimestamp":1778674376,"startTime":"0","endTime":"0","summary":"BRIEF-Moleculin Biotech Inc - To Unblind Miracle Trial Data Before June 30, 2026 - SEC FilingMay 13  - Moleculin Biotech Inc MBRX.O:MOLECULIN BIOTECH INC - TO UNBLIND MIRACLE TRIAL DATA BEFORE JUNE 30, 2026 - SEC FILINGMOLECULIN BIOTECH INC - MIRACLE TRIAL ON TRACK TO COMPLETE PART A RECRUITMENT IN Q3 2026 - SEC FILINGFurther company coverage: MBRX.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nFWN41Q11B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635535784","title":"Moleculin Biotech Inc - Miracle Trial on Track to Complete Part a Recruitment in Q3 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635535784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635535784?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:03","pubTimestamp":1778673787,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nFWN41Q11B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635843167","title":"Moleculin nears MIRACLE trial unblinding for Annamycin in relapsed AML by June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2635843167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635843167?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:02","pubTimestamp":1778673731,"startTime":"0","endTime":"0","summary":"Moleculin Biotech flagged late Q2 2026 unblinding for first 45 patients in pivotal MIRACLE trial testing Annamycin with cytarabine in relapsed or refractory acute myeloid leukemia, with results expected before June 30, 2026.Blinded interim data showed remission outcomes tracking well above historical experience for cytarabine alone, signaling potential added benefit without disclosing arm-level performance.Safety readout remained consistent with no cardiotoxicity observed to date, supporting continued development focus for Annamycin in this setting.Enrollment continued toward 90 patients for Part A in Q3 2026, keeping timeline intact for a second unblinding later in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL2XbzCP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635242898","title":"Moleculin announces publication on cardiac safety profiloe of annamycin","url":"https://stock-news.laohu8.com/highlight/detail?id=2635242898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635242898?lang=en_us&edition=fundamental","pubTime":"2026-05-13 03:17","pubTimestamp":1778613450,"startTime":"0","endTime":"0","summary":"Moleculin Biotech (MBRX) announced the publication of an abstract at the European Hematology Association 2026 Congress highlighting the cardiac saf...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moleculin-announces-publication-on-cardiac-safety-profiloe-of-annamycin-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moleculin-announces-publication-on-cardiac-safety-profiloe-of-annamycin-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPV","BK4588","BK4581","MBRX","XBI","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634127872","title":"Moleculin says Cleveland Clinic review finds no significant Annamycin cardiotoxicity in R/R AML","url":"https://stock-news.laohu8.com/highlight/detail?id=2634127872","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634127872?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:32","pubTimestamp":1778592738,"startTime":"0","endTime":"0","summary":"Moleculin Biotech flagged new pooled cardiac safety findings for its anthracycline Annamycin in relapsed or refractory acute myeloid leukemia, with results set for presentation at European Hematology Association 2026 Congress.Independent Cleveland Clinic review of multiple completed trials found no clinically meaningful treatment-related heart toxicity, including in patients treated beyond conventional lifetime exposure limits for standard anthracyclines.Analysis showed cardiac function remained stable over treatment, supporting plans to position Annamycin for heavily pretreated patients who often cannot receive further anthracycline therapy due to cardiotoxicity risk.Company framed safety profile as a potential differentiator that could expand use in AML salvage settings where current options have limited benefit.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL7GLfhY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","BK4112","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","MBRX","SG9999014039.USD","BK4585","IE00B64PRP62.GBP","IE00BN0W2W23.USD","LU0314104364.USD","BK4588","SG9999014013.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633468923","title":"Moleculin Biotech issued liposomal Annamycin patent in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2633468923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633468923?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:28","pubTimestamp":1778254134,"startTime":"0","endTime":"0","summary":"Moleculin Biotech (MBRX) announced a significant advancement in its intellectual property portfolio with the issuance of a Hong Kong patent coverin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-issued-liposomal-annamycin-patent-in-hong-kong-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-issued-liposomal-annamycin-patent-in-hong-kong-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XBI","BK4581","MBRX","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633953459","title":"Moleculin Biotech secures Hong Kong patent for liposomal Annamycin reconstitution method","url":"https://stock-news.laohu8.com/highlight/detail?id=2633953459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633953459?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:45","pubTimestamp":1778244339,"startTime":"0","endTime":"0","summary":"Moleculin Biotech won a Hong Kong patent covering its method of reconstituting liposomal Annamycin, extending protection through June 25, 2040.Patent, No. 40073244, is jointly owned with University of Texas System.Move expands intellectual property coverage for lead cancer drug candidate ahead of expected first Phase 3 data release later this quarter.Annamycin is being developed for relapsed or refractory acute myeloid leukemia, with a separate program in soft tissue sarcoma lung metastases.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL47ZCkx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","SG9999014021.USD","NDAQ","BK4139","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","SG9999014039.USD","IE00BGHQF748.EUR","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459274","title":"Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459274","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633459274?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:45","pubTimestamp":1778244300,"startTime":"0","endTime":"0","summary":"Solid Intellectual Property Protection Across Four Continents Ahead of Pending Phase 3 Data Release HOUSTON, May  08, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/08/3291067/0/en/Moleculin-Biotech-Secures-Strategic-Additional-Patent-Strengthening-Global-Positioning-of-Annamycin.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","MBRX","BK4139","BK4588","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629556831","title":"Moleculin says Annamycin extends survival 60% in pancreatic cancer preclinical models","url":"https://stock-news.laohu8.com/highlight/detail?id=2629556831","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629556831?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:25","pubTimestamp":1776947121,"startTime":"0","endTime":"0","summary":"Moleculin Biotech highlighted new preclinical pancreatic cancer data presented at AACR 2026 for liposomal Annamycin.Studies showed the drug reduced tumor growth across multiple models, supporting a potential expansion into pancreatic ductal adenocarcinoma.A metastatic model showed a clear survival benefit versus control, reinforcing potential relevance in aggressive disease.Drug distribution work indicated higher tumor and pancreatic tissue accumulation than doxorubicin, supporting a differentiated efficacy profile.Company is running its pivotal Phase 2B/3 MIRACLE trial in relapsed or refractory acute myeloid leukemia testing Annamycin with cytarabine.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDLblwQmh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00B64PRP62.GBP","LU2210150020.SGD","IE00BN0W2W23.USD","MBRX","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","BK4588","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4139","BK4112","IE00BN0W2V16.EUR","BK4585","NDAQ","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629031846","title":"Moleculin to present annamycin cardiac safety pooled analysis at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629031846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629031846?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:36","pubTimestamp":1776774981,"startTime":"0","endTime":"0","summary":"Moleculin Biotech disclosed acceptance of an abstract on its lead drug candidate annamycin for poster presentation at 2026 ASCO Annual Meeting.Data will be presented May 30, 2026, in Chicago.Poster reports pooled analysis indicating annamycin maintained a favorable cardiac safety profile in patients with high cumulative anthracycline exposure.Update supports positioning annamycin as a differentiated anthracycline candidate for patients where cardiotoxicity risk can limit use of standard therapies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL5BgpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","NDAQ","BK4112","SG9999014039.USD","BK4588","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","MBRX","BK4585","LU2095319765.USD","BK4139","LU0314104364.USD","SG9999014021.USD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014013.SGD","SG9999014005.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":76,"code":"91000000","status":"200"}]}}